BioPharm America EBD Group Massachusetts Biotechnology Council BioPharm America
Share:
Email this page Share this on LinkedIn Share this on Twitter

BioPharm America™ 2014 Press Releases

May 20, 2014Collaborative models and IPO window are hot topics at BioPharm America™ 2014 program The seventh annual BioPharm America international life science partnering conference will be held September 22–24 at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The event brings together industry thought leaders and high level executives in the biopharma dealmaking arena to collaborate on and discuss relevant trends and topics. Several i...  more ►

April 15, 2014BioPharm America™ 2014 returns to Boston's Copley Place and a celebration of the FierceBiotech Fierce 15 The seventh annual BioPharm America international life science partnering conference will be held at Boston Marriott Copley Place in the center of Boston's historic Back Bay. Produced by EBD Group in collaboration with the Massachusetts Biotechnology Council (MassBio), the September 22–24 event will bring the global life science industry to Boston to facilitate strategic ...  more ►



partnering360:Insight Latest headlines from partnering360:Insight

23 July 2014 Medtrack Unpartnered Products: Partnerships that could be Game Changers As the pharmaceutical landscape continues to consolidate through acquisitions and partnerships, Medtrack Analyst Steven Muntner examines the untapped market of unpartnered products, which represents a potential multi-billion dollar opportunity. more ►

22 July 2014 Promethera expands portfolio with progenitor cell platform Eric Halioua arrives at BioPharm America™ in Boston this September carrying an expanding portfolio of partnering opportunities based on a platform of human liver progenitor cells. more ►

22 July 2014 CoStim Pharma: People plus hot science create stunning combo-combo deal Pathways and platforms are great but true exits come around product portfolios, says Robert Millman, a founder and the chief executive for CoStim Pharmaceuticals, which was snapped up by Novartis just 10 months after the company's first funding round. more ►

21 July 2014 Recent industry analysis on distribution partnering agreements Recent industry analysis from Current Agreements shows a high volume of dealmaking activity in the distribution deal type among the pharma and biotech companies worldwide. more ►

12 May 2014 Market Update: Cancer Immunotherapy Perhaps no other recent topic in oncology has generate as much excitement as the immunotherapies. PD-1s, checkpoint inhibitors, CAR-T, and DC therapies – all have become common fare for those following cancer drug development. more ►



Arrow Up


 
 
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2014 EBD Group, Inc.
Privacy Policy
Terms of Use
BioPharm America EBD Group Massachusetts Biotechnology Council BioPharm America